Accueil
Explorer
nav.journalClub
Tendances
Plus
Synapse
⌘+K
Synapse
Langue
Français
Français
RETRACTION: Atractylenolide III alleviates sepsis-mediated lung injury via inhibition of FoxO1 and VNN1 protein | Synapse
February 13, 2026
Open Access
RETRACTION: Atractylenolide III alleviates sepsis-mediated lung injury via inhibition of FoxO1 and VNN1 protein
Key Points
This work aimed to explore how Atractylenolide III affects lung injury caused by sepsis.
Analyzed the efficacy of Atractylenolide III in a sepsis model
Examined interactions with FoxO1 and VNN1 proteins
Atractylenolide III improved lung injury outcomes
Decreased activity of FoxO1 and VNN1 proteins
Abstract
This retracts the article doi: 10.1590/ACB360802.
Read Full Paper
externally
Demander à l'IA
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Cite This Study
Copy
A Thu, study studied this question.
synapsesocial.com/papers/698ebeb185a1ff6a93016015
https://doi.org/https://doi.org/10.1590/acb360802.retraction
Demander à l'IA
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper